menu
    • menu

    Company profile for Veraxa Biotech

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VERAXA Biotech is a next-generation antibody therapeutics pioneer, leveraging breakthrough science from EMBL to develop transformative ADC and BiTAC TCE platforms. Our quality-by-design approach accelerates novel biologics from discovery to clinical development, targeting oncology and complex diseases with precision. By combining proprietary technologies with deep antibody expertise, we're building a diversified pipeline of be...
    VERAXA Biotech is a next-generation antibody therapeutics pioneer, leveraging breakthrough science from EMBL to develop transformative ADC and BiTAC TCE platforms. Our quality-by-design approach accelerates novel biologics from discovery to clinical development, targeting oncology and complex diseases with precision. By combining proprietary technologies with deep antibody expertise, we're building a diversified pipeline of best-in-class therapies to address unmet medical needs globally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Veraxa BiotechGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Im Neuenheimer Feld 584 69120 Heidelberg
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.veraxa.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VERAXA Biotech Shareholders Approve Merger With Voyager
    VERAXA Biotech Shareholders Approve Merger With Voyager

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247012/0/en/VERAXA-Biotech-Shareholders-Approve-Merger-and-Issuance-of-New-Shares-to-Voyager-Acquisition-Corp.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Veraxa Biotech, Secarna Pharma Launch Immunology
    Veraxa Biotech, Secarna Pharma Launch Immunology

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158495/0/en/VERAXA-Biotech-and-Secarna-Pharmaceuticals-Initiate-Antibody-Oligonucleotide-Conjugate-Alliance-in-Immunology.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    VERAXA & Voyager File Form F-4 for Proposed Merger
    VERAXA & Voyager File Form F-4 for Proposed Merger

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3116951/0/en/VERAXA-Biotech-and-Voyager-Acquisition-Corp-Announce-Filing-of-Form-F-4-Registration-Statement-with-the-SEC.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    VERAXA Biotech to Showcase BiTAC at Industry Conferences
    VERAXA Biotech to Showcase BiTAC at Industry Conferences

    29 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/29/3090517/0/en/VERAXA-Biotech-to-Attend-Key-Industry-Conferences-to-Showcase-BiTAC-Technology-Platform.html

    GLOBENEWSWIRE
    29 May 2025
    Share Share
    VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
    VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

    20 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/20/3084508/0/en/VERAXA-Biotech-Appoints-Rick-Austin-as-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    20 May 2025
    Share Share
    VERAXA Biotech partners with OmniAb for Bispecific Antibody Drug
    VERAXA Biotech partners with OmniAb for Bispecific Antibody Drug

    05 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/05/3073751/0/en/VERAXA-Biotech-Enters-Co-discovery-Alliance-with-OmniAb-for-a-Novel-Bispecific-Antibody-Drug-Conjugate-Program.html

    GLOBENEWSWIRE
    05 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search